Nothing said here yet.
to join the conversation.
| Soares KarenChief Legal Officer | Sell | 19,275 | $89.8K | Tue, Oct 20 |
| Reynoso Jamie L.CEO, Medicare Advantage | Sell | 4,066 | $17.9K | Mon, Oct 19 |
| Toy AndrewChief Executive Officer | Sell | 62,176 | $291.0K | Thu, Oct 15 |
| Wai ConradCEO, Counterpart Health | Sell | 23,627 | $110.6K | Thu, Oct 15 |
| Reynoso Jamie L.CEO, Medicare Advantage | Sell | 18,273 | $85.5K | Thu, Oct 15 |
| Soares KarenChief Legal Officer | Sell | 14,673 | $68.7K | Thu, Oct 15 |
| THORNTON JOSEPH CLAYInterim CFO | Sell | 4,591 | $21.5K | Thu, Oct 15 |
| Reynoso Jamie L.CEO, Medicare Advantage | Sell | 2,006 | $9.3K | Wed, Oct 7 |
| Reynoso Jamie L.CEO, Medicare Advantage | Sell | 8,750 | $38.7K | Mon, Oct 5 |
| Toy AndrewChief Executive Officer | Sell | 318,806 | $1.3M | Thu, Oct 1 |
| Reynoso Jamie L.CEO, Medicare Advantage | Sell | 1,921 | $8.8K | Thu, Sep 17 |
| OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER | Sell | 3,170 | $14.7K | Wed, Sep 16 |
What a time it’s been for Clover Health. In the past six months alone, the company’s stock price has increased by a massive 74.4%, reaching $4.61 per share.
Investing.com -- Clover Health Investments Corp (NASDAQ:CLOV) shares advanced 4% in Wednesday trading after Needham initiated coverage on the healthcare technology company with a Buy rating and a $6.00 price target.
Clover Health Investments recently outlined its 2027 Medicare Advantage portfolio, highlighting $0-premium PPO options, low specialist copays, broad provider choice, and Clover Assistant-powered clinical decision support across a consistent five-state…
Clover Health Investments has seen its stock price move sharply in recent years, which puts fresh focus on whether today's valuation lines up with the revenue the business is generating.
Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 10.7% in the pre-market session after the company announced that the Centers for Medicare & Medicaid Services awarded its PPO Medicare Advantage plans a 5-Star rating and its HMO Medicare…